Financials Dr. Miele Cosmed Group S.A. Deutsche Boerse AG

Equities

9PU

PLGLBLC00011

Personal Products

Delayed Deutsche Boerse AG 02:46:35 2024-06-20 EDT 5-day change 1st Jan Change
0.8 EUR +2.04% Intraday chart for Dr. Miele Cosmed Group S.A. +2.04% +10.50%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 82.01 108.3 384.3 400.4 178.2 276.9
Enterprise Value (EV) 1 148.3 169.5 428.9 444.3 235.6 322.5
P/E ratio -11.9 x 32.4 x 13.4 x 35.3 x -68 x 12.7 x
Yield - - 1.36% 0.65% - 2.84%
Capitalization / Revenue 0.27 x 0.35 x 1.05 x 1.14 x 0.45 x 0.62 x
EV / Revenue 0.49 x 0.55 x 1.18 x 1.26 x 0.59 x 0.73 x
EV / EBITDA 14.8 x 9.42 x 10.6 x 18.3 x 22 x 7.59 x
EV / FCF 8.3 x 19.6 x 70.6 x 106 x -99.4 x 29.7 x
FCF Yield 12% 5.11% 1.42% 0.94% -1.01% 3.36%
Price to Book 0.46 x 0.59 x 1.81 x 1.84 x 0.84 x 1.18 x
Nbr of stocks (in thousands) 86,326 87,339 87,339 87,339 87,339 87,339
Reference price 2 0.9500 1.240 4.400 4.585 2.040 3.170
Announcement Date 19-04-02 20-03-23 21-04-12 22-04-19 23-05-02 24-04-25
1PLN in Million2PLN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 300.8 309.9 364.8 351.9 396.6 444.5
EBITDA 1 10 17.98 40.53 24.29 10.69 42.47
EBIT 1 -0.416 8.771 31.32 15.17 1.17 32.89
Operating Margin -0.14% 2.83% 8.59% 4.31% 0.3% 7.4%
Earnings before Tax (EBT) 1 -3.505 4.929 31.3 13.26 -2.096 27.2
Net income 1 -6.58 3.345 28.63 11.6 -2.266 22.22
Net margin -2.19% 1.08% 7.85% 3.3% -0.57% 5%
EPS 2 -0.0800 0.0383 0.3278 0.1300 -0.0300 0.2500
Free Cash Flow 1 17.86 8.66 6.074 4.189 -2.371 10.84
FCF margin 5.94% 2.79% 1.67% 1.19% -0.6% 2.44%
FCF Conversion (EBITDA) 178.56% 48.17% 14.99% 17.25% - 25.53%
FCF Conversion (Net income) - 258.91% 21.22% 36.12% - 48.8%
Dividend per Share - - 0.0600 0.0300 - 0.0900
Announcement Date 19-04-02 20-03-23 21-04-12 22-04-19 23-05-02 24-04-25
1PLN in Million2PLN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 66.3 61.2 44.6 43.9 57.5 45.6
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 6.625 x 3.401 x 1.1 x 1.806 x 5.375 x 1.074 x
Free Cash Flow 1 17.9 8.66 6.07 4.19 -2.37 10.8
ROE (net income / shareholders' equity) -3.57% 1.83% 14.4% 5.4% -1.05% 9.94%
ROA (Net income/ Total Assets) -0.08% 1.67% 5.85% 2.68% 0.2% 5.43%
Assets 1 8,658 200.5 488.9 433.4 -1,140 409
Book Value Per Share 2 2.070 2.110 2.430 2.490 2.430 2.680
Cash Flow per Share 2 0.0500 0.0600 0.2100 0.1300 0.1100 0.1600
Capex 1 8.05 3.57 8.84 17.7 6.55 9.69
Capex / Sales 2.67% 1.15% 2.42% 5.04% 1.65% 2.18%
Announcement Date 19-04-02 20-03-23 21-04-12 22-04-19 23-05-02 24-04-25
1PLN in Million2PLN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. DMG Stock
  4. 9PU Stock
  5. Financials Dr. Miele Cosmed Group S.A.